Influence of microscopically positive resection margins on long-term (>5-year) survival after resection of pancreatic ductal adenocarcinoma.

نویسندگان

  • Yoshihiro Hamada
  • Kensei Maeshiro
  • Yoshifuku Nakayama
چکیده

CONTEXT The impact of R1 resection on outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) is unclear, with most studies assessing survival for up to 5 years. OBJECTIVE The aim of this study was to evaluate the prognostic influence of R1 and R0 resection on >5-year survival in patients with PDAC. MATERIAL AND METHODS Of the 271 patients with PDAC who underwent pancreatic resection over a 26-year period, 33 had survived for ≥5 years. R1 status was defined as the presence of tumor tissue ≤1 mm from a circumferential margin surface. Patients were followed-up for 61 to 288 months. RESULTS Of the 33 long-term survivors, 19 and 14 underwent R0 and R1 resection, respectively. The percentage of male patients was significantly higher in the R1 than in the R0 group. The R0 group tended to show a weaker relationship between R status and stage than the R1 group. Multivariate analysis showed that R status was an independent prognostic marker (P=0.0071), and Kaplan-Meier curves showed that >5-year survivors in the R1 group had significantly poorer prognoses (P=0.002). CONCLUSIONS Patients who have survived >5 years following R1 resection for PDAC can experience tumor recurrence in the resected area.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.

BACKGROUND Pancreatic ductal adenocarcinoma represents 90% of pancreatic cancers and is an important cause of cancer death in the United States. Operative resection remains as the only treatment providing prolonged survival, but even after a curative resection, 5-year survival rates are low. Our aim was to identify the prognostic factors for long-term survival after resection of pancreatic duct...

متن کامل

The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma

BACKGROUND The prognosis of pancreatic ductal adenocarcinoma (PDAC) is worse when the tumor is located in the pancreatic body or tail, compared to being located in the pancreatic head. However, for localized, resectable tumors survival seems to be at least similar. METHODS We analyzed and compared the outcome after pancreatoduodenectomy (PD) and distal pancreatectomy (DP) for PDAC at our inst...

متن کامل

The 5-year survival rate for patients with histologically confirmed metastatic ductal adenocarcinoma of the pancreas approaches 0%,with a median overall survival

Cancer Control 295 Introduction The 5-year survival rate for patients with histologically confirmed metastatic ductal adenocarcinoma of the pancreas approaches 0%,with a median overall survival of 5 to 6 months.1-3 Long-term survival after a diagnosis of pancreatic cancer is attained only in patients who are diagnosed prior to the development of distant metastasis and are able to undergo comple...

متن کامل

Acstract. Background: Excessive blood loss and blood transfusion may influence postoperative complications and prognosis of patients after pancreatic resection. We evaluated the influence of blood products use on postoperative recurrence and outcome of patients with pancreatic ductal

transfusion may influence postoperative complications and prognosis of patients after pancreatic resection. We evaluated the influence of blood products use on postoperative recurrence and outcome of patients with pancreatic ductal adenocarcinoma. Patients and Methods: The study included 82 patients who underwent elective pancreatic resections for pancreatic ductal adenocarcinoma without distan...

متن کامل

Radiologic Resectability Assessment in Pancreatic Cancer Radiologische Einschätzung der Resektabilität beim Pankreaskarzinom

Although notable progress in diagnosis and therapy has been made in recent years, the 5-year survival of patients diagnosed with ductal adenocarcinoma of the pancreas is still less than 5% [1]. To date, surgery is the only curative option for patients suffering from this aggressive entity. Nowadays in high-volume centers, this procedure can be performed with a mortality of 1–3% and morbidity of...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • JOP : Journal of the pancreas

دوره 15 5  شماره 

صفحات  -

تاریخ انتشار 2014